Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Fox

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Polymers|September 28, 2023
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer PolymerizationCordula S Hege, Amy Stimpson, Joseph Sefton, et al.
Plos One|June 4, 2020
Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in BrazilMilena Apetito Akamatsu, Vitor Anselmo Sakihara, Bianca Pereira Carvalho, et al.
Journal of Virology|August 10, 2018
Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus MacaquesBonnie Phillips, Koen K A Van Rompay, Jennifer Rodriguez-Nieves, et al.
NPJ Vaccines|February 16, 2023
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsionsKarl J Fisher, Robert Kinsey, Raodoh Mohamath, et al.
Nature Communications|March 6, 2023
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adultsZachary K Sagawa, Cristina Goman, Aude Frevol, et al.
Human Vaccines & Immunotherapeutics|August 2, 2024
Immunogenicity and safety of an <i>Entamoeba histolytica</i> adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaquesMayuresh M Abhyankar, Feifan Xu, Deborah Chavez, et al.
Frontiers in Pharmacology|February 7, 2022
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse ModelMellissa Gomez, Mushtaq Ahmed, Shibali Das, et al.
Organic Process Research & Development|March 25, 2024
Kilo-Scale GMP Synthesis of Renewable Semisynthetic Vaccine-Grade SqualeneKarl J Fisher, Laura Shirtcliff, Greg Buchanan, et al.
Frontiers in Drug Delivery|September 29, 2023
Lyophilization Process Engineering and Thermostability of ID93 + GLA-SE, a Single-Vial Adjuvanted Subunit Tuberculosis Vaccine Candidate for Use in Clinical StudiesTimothy S Dutill, Michelle C Archer, Joseph McCollum, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Polymers|September 28, 2023
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer PolymerizationCordula S Hege, Amy Stimpson, Joseph Sefton, et al.
Plos One|June 4, 2020
Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in BrazilMilena Apetito Akamatsu, Vitor Anselmo Sakihara, Bianca Pereira Carvalho, et al.
Journal of Virology|August 10, 2018
Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus MacaquesBonnie Phillips, Koen K A Van Rompay, Jennifer Rodriguez-Nieves, et al.
NPJ Vaccines|February 16, 2023
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsionsKarl J Fisher, Robert Kinsey, Raodoh Mohamath, et al.
Nature Communications|March 6, 2023
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adultsZachary K Sagawa, Cristina Goman, Aude Frevol, et al.
Human Vaccines & Immunotherapeutics|August 2, 2024
Immunogenicity and safety of an <i>Entamoeba histolytica</i> adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaquesMayuresh M Abhyankar, Feifan Xu, Deborah Chavez, et al.
Frontiers in Pharmacology|February 7, 2022
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse ModelMellissa Gomez, Mushtaq Ahmed, Shibali Das, et al.
Organic Process Research & Development|March 25, 2024
Kilo-Scale GMP Synthesis of Renewable Semisynthetic Vaccine-Grade SqualeneKarl J Fisher, Laura Shirtcliff, Greg Buchanan, et al.
Frontiers in Drug Delivery|September 29, 2023
Lyophilization Process Engineering and Thermostability of ID93 + GLA-SE, a Single-Vial Adjuvanted Subunit Tuberculosis Vaccine Candidate for Use in Clinical StudiesTimothy S Dutill, Michelle C Archer, Joseph McCollum, et al.
Pageof 15